Updated Criteria for Inappropriate Medication Use in Elderly Persons

News
Article

A consensus panel of experts recently updated the Beerscriteria, one of the most widely used guidelines for medicationuse in older adults.1 Listed in the Table are medicationsthat should generally be avoided in persons aged 65and older-regardless of diagnosis or condition-eitherbecause the agents are ineffective in these patients or becausethey pose unnecessarily high risks.

A consensus panel of experts recently updated the Beerscriteria, one of the most widely used guidelines for medicationuse in older adults.1 Listed in the Table are medicationsthat should generally be avoided in persons aged 65and older--regardless of diagnosis or condition--eitherbecause the agents are ineffective in these patients or becausethey pose unnecessarily high risks.

References:

REFERENCE:
1

. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentiallyinappropriate medication use in older adults: results of a US consensuspanel of experts. Arch Intern Med. 2003;163:2716-2724.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020

Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020

Sydney Jennings
July 14th 2025
Article

ENDO 2025. Older adults, rural populations, and residents in the Midwest experienced the highest mortality rates, according to new data.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

Sydney Jennings
July 14th 2025
Article

FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Sydney Jennings
June 11th 2025
Podcast

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

HHS Secretary RFK, Jr, Cancels This Week's USPSTF Meeting, Prompting Fear Among Primary Care Professional Groups

HHS Secretary RFK, Jr, Cancels July 10 USPSTF Meeting, Prompting Fear Across Primary Care Professional Groups

Austin Littrell
July 11th 2025
Article

The abrupt cancellation, without warning or cause, has medical groups and health care leaders concerned about patient access to no-cost preventive services.

Machine Learning Tool Detects Severe Subjective Cognitive Decline in Menopausal Women / image courtesy of Shandong University

Machine Learning Predicts Subjective Cognitive Decline During Menopause: Novel Framework for Early Detection

Grace Halsey
July 11th 2025
Article

Key predictors of the severity of self-reported cognitive complaints among nurses going through menopause included symptom severity and climacteric stage.

© 2025 MJH Life Sciences

All rights reserved.